Sponsor

Kyowa Kirin, Inc.

Clinical research sponsor

Published trials13
Recruiting shown1
Roles2
SourceClinicalTrials.gov

Clinical trials

13 shown
Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung CancerNCT02358473 · lead sponsor · 2015-01-01
COMPLETED
An Extension of Istradefylline in North American Parkinson's Disease Patients Who Have Completed Study 6002-INT-001NCT00199381 · lead sponsor · 2005-10-01
TERMINATED
A Study of Istradefylline (KW-6002) as Monotherapy in Parkinson's Disease (PD) PatientsNCT00199433 · lead sponsor · 2005-05-01
COMPLETED
An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018NCT00199368 · lead sponsor · 2004-10-01
COMPLETED
A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on LevodopaNCT00199420 · lead sponsor · 2004-07-01
COMPLETED
A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking LevodopaNCT00199407 · lead sponsor · 2004-06-01
COMPLETED
A Long-Term, Safety Study With a Flexible Dose Range of KW-6002 in Patients With Motor Response Complications on Levodopa/Carbidopa TherapyNCT00955045 · lead sponsor · 2002-08-01
COMPLETED
12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/CarbidopaNCT00456586 · lead sponsor · 2002-04-01
COMPLETED
12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/CarbodopaNCT00456794 · lead sponsor · 2002-03-01
COMPLETED
A Study of KK2269 in Adult Participants With Solid TumorsNCT06266299 · collaborator · 2024-01-18
RECRUITING
Istradefylline Effect Protocol on Parkinson's Disease TremorNCT05885360 · collaborator · 2023-01-20
COMPLETED
Effect of Istradefylline Treatment on Behavioral Measures of Apathy in Parkinson's Disease.NCT05182151 · collaborator · 2022-07-29
TERMINATED
Istradefylline for Parkinson Disease With Cognitive ImpairmentNCT05333549 · collaborator · 2022-07-18
COMPLETED

Sponsor roles

lead sponsor9
collaborator4

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.